Clementia Pharmaceuticals Overview

Life ScienceCompany

Where is Clementia Pharmaceuticals headquartered?

Clementia Pharmaceuticals is headquartered in Montreal, Quebec.

What sector is Clementia Pharmaceuticals in?

Clementia Pharmaceuticals is a life science company.

When was Clementia Pharmaceuticals founded?

Clementia Pharmaceuticals was founded in 2010.

Clementia Pharmaceuticals, Inc.

4150 Sainte-Catherine Street West, Suite 550,
Montreal, Quebec H3Z 2Y5
Canada,
(514) 940-3600
www.clementiapharma.com

Clementia Pharmaceuticals, Inc. is a clinical-stage company innovating treatments for people with ultra-rare bone disorders and other diseases with a high medical need. The company is preparing for a 2019 NDA submission to the FDA to seek approval of its lead product candidate, palovarotene, a novel RARγ agonist, for the prevention of heterotopic ossification (HO) associated with flare-up symptoms in adults and children with fibrodysplasia ossificans progressiva (FOP). Clementia Pharmaceuticals was founded in 2010 and is based in Montreal, Quebec.



Try Mergr Free — See This and 221,260+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 215K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.